S
SOLASTA Bio
Food · Glasgow, United Kingdom · Founded 2020
Nature-inspired, peptide-based bioinsecticides for targeted pest control MoreLess
SOLASTA Bio is a UK-based agricultural biotechnology company developing a new generation of green insecticides. Founded in 2020 as a spin-out from the University of Glasgow by Professor Shireen Davies, Professor Julian Dow, and Paul Bernasconi, the company is built on four years of prior research. Davies, who serves as CEO, has a background in insect neuroendocrinology, while CSO Julian Dow is an expert in insect biology and functional genomics.
The company has created the world's first technology platform for developing neuropeptide-based insect control agents (ICAs). Unlike traditional synthetic chemical pesticides, SOLASTA Bio's products are nature-inspired and derived from peptides that are integral to an insect's metabolism. This allows for a highly specific mode of action that targets physiological functions in pest insects while remaining non-toxic to beneficial species like pollinators, as well as to humans and the wider environment. The products are biodegradable and do not accumulate in nature. This approach addresses key market challenges such as widespread insect resistance to chemical pesticides and the negative ecological impact of conventional crop protection methods.
SOLASTA Bio's business model centers on the development and commercialization of these proprietary bioinsecticides. The company targets the global agricultural industry, providing growers with a safer and more sustainable alternative for crop protection that has demonstrated efficacy on par with or better than commercial standards in multiple field trials. Its platform can be adapted for any pest of interest across both crop and non-crop applications, such as stored grain. The company has raised a total of $19 million, including a $14 million Series A round in September 2024, with investors like Forbion, FMC Ventures, and Corteva Catalyst. This funding is aimed at accelerating development, scaling up manufacturing, expanding US operations from its North Carolina base, and preparing for a targeted market entry by 2027.
Keywords: bioinsecticides, peptide-based pest control, agritech, crop protection, sustainable agriculture, neuropeptides, green insecticides, pollinator safety, biological pesticides, pest management, agricultural biotechnology, food security, insect control agents, venture capital, University of Glasgow spin-out, biopesticides, crop science, sustainable farming, non-toxic pesticides, biodiversity preservation
Company overview
SOLASTA Bio company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2020
- Headquarters
- Glasgow, United Kingdom
- Employees
- 38
- Open positions
- None listed
- Dealroom signal
- 81.2
Valuation & funding
SOLASTA Bio funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Sep 2024 | $14M | $56M | SIS Ventures · University of Glasgow · Cavallo Ventures · Forbion Capital Partners | ↗ |
| GRANT✓Other financing | Mar 2024 | $1M | — | UPL | ↗ |
| GRANT✓Other financing | Apr 2023 | — | — | Scottish Enterprise Growth Investments · UK Research and Innovation | — |
| SEED✓Equity / VC | Apr 2023 | $5.3M | $21M | Scottish Enterprise Growth Investments · Rubio Impact Ventures · Future Planet Capital · The Yield Lab | ↗ |
| GRANT✓Other financing | Aug 2022 | $1.5M | — | Undisclosed | — |
| SEED✓Equity / VC | Aug 2021 | Future Planet Capital · The Yield Lab · SIS Ventures · Scottish Enterprise Growth Investments | — | ||
| SEED✓Equity / VC | Jan 2021 | Scottish Enterprise Growth Investments · Future Planet Capital | — | ||
| SPINOUT✓Other financing | May 2020 | University of Glasgow | ↗ |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 38 |
| 2025 | 39 |
| 2024 | 29 |
| 2023 | 30 |
| 2022 | 18 |
Growth signals
SOLASTA Bio website traffic
Latest recorded traffic for SOLASTA Bio is 90 monthly website visits, down 94.7% over the last three months. SOLASTA Bio's team declined 2.6% over the past year.
Comparisons
SOLASTA Bio compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
SOLASTA Bio's talent
Source: Dealroom Talent Intelligence.
Investors
13 investors on SOLASTA Bio's cap table
Sourced from Dealroom's funding and investor records.












Global footprint
Where SOLASTA Bio has talent and traffic
team presence
In the news
Latest news about SOLASTA Bio
Recent press, funding announcements, and product moves mentioning SOLASTA Bio — open to read from the original sources.
Market sentiment
What the market is saying about SOLASTA Bio
An AI-synthesized read of the highest-engagement posts about SOLASTA Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See SOLASTA Bio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







